Basic Information
RNALocate ID: | RLID:11001311 |
RNA Symbol: | hsa-miR-129-5p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-129-5p |
RNA ID: | miRBase:MIMAT0000242 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 21505438 |
Tissue/Cell Line: | Jurkat-derived T cell line (J77cl20) |
Method: | Microarray |
Description: | Microarray analysis of exosomal miRNAs verses the miRNAs of their respective donor cells. Data are collected from Supplementary Data 1. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:11001312 | Exosome | Renal cancer cells | 21670082 |
RLID:11001313 | Exosome | Brain tissue | 23382797 |
RLID:11001314 | Exosome | Plasma | 23663360 |
RLID:11001315 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11001316 | Microvesicle | Cerebrospinal fluid | 24797360 |
RLID-D:11000040 | Exosome | Blood | |
RLID-D:11000309 | Microvesicle | Blood|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-129-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-09946 |
MNDR | hsa-miR-129-5p | Medulloblastoma | MNDR-E-MI-09947 |
MNDR | hsa-miR-129-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-09948 |
MNDR | hsa-miR-129-5p | Autism spectrum disorder | MNDR-E-MI-09949 |
MNDR | hsa-miR-129-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-09950 |
MNDR | hsa-miR-129-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-09951 |
MNDR | hsa-miR-129-5p | Triple negative breast cancer | MNDR-E-MI-09952 |
MNDR | hsa-miR-129-5p | Breast cancer luminal | MNDR-E-MI-09953 |
MNDR | hsa-miR-129-5p | Small intestine cancer | MNDR-E-MI-09954 |
MNDR | hsa-miR-129-5p | Prostate cancer | MNDR-E-MI-09955 |
MNDR | hsa-miR-129-5p | Gastric cancer | MNDR-E-MI-09956 |
MNDR | hsa-miR-129-5p | Alzheimer disease | MNDR-E-MI-09957 |
MNDR | hsa-miR-129-5p | Bladder cancer | MNDR-E-MI-09958 |
MNDR | hsa-miR-129-5p | Esophageal carcinoma | MNDR-E-MI-09959 |
MNDR | hsa-miR-129-5p | Primary biliary cirrhosis | MNDR-E-MI-09960 |
MNDR | hsa-miR-129-5p | Huntington disease | MNDR-E-MI-09961 |
MNDR | hsa-miR-129-5p | Chorea | MNDR-E-MI-09962 |
MNDR | hsa-miR-129-5p | Cardiovascular disease | MNDR-E-MI-09963 |
MNDR | hsa-miR-129-5p | Lung cancer | MNDR-E-MI-09964 |
MNDR | hsa-miR-129-5p | Endometrial cancer | MNDR-E-MI-09965 |
MNDR | hsa-miR-129-5p | Fragile x syndrome | MNDR-E-MI-09966 |
MNDR | hsa-miR-129-5p | Parkinson disease | MNDR-E-MI-09967 |
MNDR | hsa-miR-129-5p | Breast cancer | MNDR-E-MI-09968 |
MNDR | hsa-miR-129-5p | Thyroid cancer | MNDR-E-MI-09969 |
MNDR | hsa-miR-129-5p | Pituitary neoplasms | MNDR-E-MI-09970 |
MNDR | hsa-miR-129-5p | Pancreatic cancer | MNDR-E-MI-09971 |
MNDR | hsa-miR-129-5p | Malignant melanoma | MNDR-E-MI-09972 |
MNDR | hsa-miR-129-5p | Rectum adenocarcinoma | MNDR-E-MI-09973 |
MNDR | hsa-miR-129-5p | Nephroblastoma | MNDR-E-MI-09974 |
MNDR | hsa-miR-129-5p | Colon cancer | MNDR-E-MI-09975 |
MNDR | hsa-miR-129-5p | Colon adenocarcinoma | MNDR-E-MI-09976 |
MNDR | hsa-miR-129-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-09977 |
MNDR | hsa-miR-129-5p | Familial ovarian cancer | MNDR-E-MI-09978 |
MNDR | hsa-miR-129-5p | Prostate adenocarcinoma | MNDR-E-MI-09979 |
MNDR | hsa-miR-129-5p | Laryngeal squamous cell carcinoma | MNDR-E-MI-09980 |
MNDR | hsa-miR-129-5p | Carcinoma ductal breast | MNDR-E-MI-09981 |
MNDR | hsa-miR-129-5p | Glioblastoma | MNDR-E-MI-09982 |
MNDR | hsa-miR-129-5p | Astrocytoma | MNDR-E-MI-09983 |
MNDR | hsa-miR-129-5p | Glioma | MNDR-E-MI-09984 |
MNDR | hsa-miR-129-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-09985 |
MNDR | hsa-miR-129-5p | Epilepsy temporal lobe | MNDR-E-MI-09986 |
MNDR | hsa-miR-129-5p | Osteosarcoma | MNDR-E-MI-09987 |
MNDR | hsa-miR-129-5p | Chondrosarcoma | MNDR-E-MI-09988 |
MNDR | hsa-miR-129-5p | Gastric adenocarcinoma | MNDR-E-MI-09989 |
MNDR | hsa-miR-129-5p | Cervical squamous cell carcinoma | MNDR-E-MI-09990 |
MNDR | hsa-miR-129-5p | Lung squamous cell carcinoma | MNDR-E-MI-09991 |
MNDR | hsa-miR-129-5p | Non-small cell lung cancer | MNDR-E-MI-09992 |
MNDR | hsa-miR-129-5p | Lung adenocarcinoma | MNDR-E-MI-09993 |
MNDR | hsa-miR-129-5p | Thyroid carcinoma | MNDR-E-MI-09994 |
MNDR | hsa-miR-129-5p | Medullary thyroid carcinoma | MNDR-E-MI-09995 |
MNDR | hsa-miR-129-5p | Thyroid medullary carcinoma | MNDR-E-MI-09996 |
MNDR | hsa-miR-129-5p | Bladder urothelial carcinoma | MNDR-E-MI-09997 |
MNDR | hsa-miR-129-5p | Pancreatic adenocarcinoma | MNDR-E-MI-09998 |
MNDR | hsa-miR-129-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-09999 |
MNDR | hsa-miR-129-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-10000 |
MNDR | hsa-miR-129-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-10001 |
MNDR | hsa-miR-129-5p | Clear cell renal cell carcinoma | MNDR-E-MI-10002 |
MNDR | hsa-miR-129-5p | Cholangiocarcinoma | MNDR-E-MI-10003 |
MNDR | hsa-miR-129-5p | Lung small cell carcinoma | MNDR-E-MI-10004 |
MNDR | hsa-miR-129-5p | Breast invasive carcinoma | MNDR-E-MI-10005 |
MNDR | hsa-miR-129-5p | Hepatocellular carcinoma | MNDR-E-MI-10006 |
MNDR | hsa-miR-129-5p | Familiar ovarian carcinoma | MNDR-E-MI-10007 |
MNDR | hsa-miR-129-5p | B-cell lymphoma | MNDR-E-MI-10008 |
MNDR | hsa-miR-129-5p | Malignant pleural mesothelioma | MNDR-E-MI-10009 |
MNDR | hsa-miR-129-5p | Hodgkin lymphoma | MNDR-E-MI-10010 |
MNDR | hsa-miR-129-5p | Burkitt lymphoma | MNDR-E-MI-10011 |
MNDR | hsa-miR-129-5p | Tonsil cancer | MNDR-E-MI-10012 |
MNDR | hsa-miR-129-5p | Colorectal cancer | MNDR-E-MI-10013 |
MNDR | hsa-miR-129-5p | Nasopharynx carcinoma | MNDR-E-MI-10014 |
MNDR | hsa-miR-129-5p | Ependymoma | MNDR-E-MI-10015 |
MNDR | hsa-miR-129-5p | Nasopharyngeal cancer | MNDR-E-MI-10016 |
MNDR | hsa-miR-129-5p | AIDS dementia complex | MNDR-E-MI-10017 |
MNDR | hsa-miR-129-5p | Stroke lacunar | MNDR-E-MI-10018 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABCB1 | Homo sapiens | RR00022773 |
TOP